Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

Chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated both efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients infected with hepatitis B virus (HBV). However, its applicability in individuals with liver cirrhosis remains largely unexplored due to the...

Descripció completa

Dades bibliogràfiques

Autors principals:	Danqing Kong, Nana Ping, Qian Zhu, Xiao Zhang, Junhong Li, Rui Zou, Depei Wu, Zhengming Jin, Changju Qu
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-12-01
Col·lecció:	Frontiers in Oncology
Matèries:	diffuse large B-cell lymphoma cirrhosis chimeric antigen receptor T-cell therapy hepatitis B virus case report
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1491100/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!